Dyne Therapeutics, Inc. DYN Return on invested capital

Return on invested capital at other companies

Ionis PharmaceuticalsIONS

-80.3%+2,757pp

Arrowhead ResearchARWR

-38.8%+135pp

Solid Biosciences Inc.SLDB

-112.5%-5.3pp

Edgewise Therapeutics, Inc.EWTX

-47.1%+14.7pp

Design Therapeutics, Inc.DSGN

-37.1%+12.1pp

Scholar RockSRRK

-500.4%+7,305pp

FAQ

What is Dyne Therapeutics, Inc.'s return on invested capital?

Dyne Therapeutics, Inc. (DYN) reported return on invested capital of -188.2% in Q1 2026.

How has Dyne Therapeutics, Inc.'s return on invested capital changed year-over-year?

Dyne Therapeutics, Inc.'s return on invested capital decreased by 7.3% year-over-year, from -175.4% to -188.2%.

What is the long-term trend for Dyne Therapeutics, Inc.'s return on invested capital?

Over 2 years (2021 to 2025), Dyne Therapeutics, Inc.'s return on invested capital has grown at a 27.3% compound annual growth rate (CAGR), from -123.8% to -200.8%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.